Associate Professor of Obstetrics and Gynecology, Va Commonwealth University School of Medicine
Obstetrics & Gynecology
Dr. Cecelia H. Boardman, MD
|
|
Give Review
Cecelia Boardman works in the field of Obstetrics & Gynecology. She attended Perelman School of Medicine at the University of Pennsylvania. She received awards:"Regional Top Doctor", "Fellow (FACS)" and "Fellow (FACOG)". Cecelia Boardman has written publications. She has 22 publications published with PubMed. The lastest publication is: 'A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera.' She accepts all Medicare patients.
Publications
- Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study.
- Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gyn...
- Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.
- Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic On...
- Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.
- Biologic therapeutics and molecular profiling to optimize wound healing.
- Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
- Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
- Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer.
- A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients.
- A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women.
- Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
- A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera.
- EGF/ErbB receptor family in ovarian cancer.
- Preventive gynecologic surgery for BRCA1/2 carriers--information for decision-making.
- Transitional cell carcinoma of the bladder mimicking recurrent paget's disease of the vulva: report of two cases, with one occurring in a myocutaneous flap.
- Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer.
- Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy.
- Peritoneal carcinomatosis from cervical cancer detected by F-18 FDG positron emission tomography.
- Surgery in ovarian cancer.
- Airbag deployment following a motor vehicle accident in pregnancy.
Schools
University Of Pennsylvania School Of Medicine
Magee Womens Hospital University Of Pittsburgh
Magee Womens Research Institute
Mayo Clinic
Procedures Preformed
- Colporrhaphy
- Colposcopy
- Contraceptive Management
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FACS)
- Fellow (FACOG)
Education
-
Perelman School of Medicine at the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1528158326 | |
| NPPES Provider LastName | BOARDMAN | |
| NPPES Provider FirstName | CECELIA | |
| NPPES Provider ZIPCode | 232294942 | |
| NPPES Provider State | VA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 298.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 15.0 | |
| Percent Opioid Claims | 5.03 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528158326 |
| Last Name Of The Provider | BOARDMAN |
| First Name Of The Provider | CECELIA |
| View All |
Similar Doctors
|
Dr. Harry W. Royal, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Sumac D. Diaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George Chamoun, DO |
|
|
Dr. Charles E. Welander, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Megan K. Cassidy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Weldon E. Chafe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leo J. Dunn, MD |
|
Dr. Tyler C. Ford, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Johnny Hyde Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles M. Jones III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie L. Blommel, MD
This Doctor is OpenDoctor Recommended.
|